Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
12/02/2026 12:28
Feb 12 (Reuters) - Kane Biotech Inc KNE.V: KANE BIOTECH RESTARTS COMMERCIAL ACTIVITIES AND STRENGTHENS NORTH AMERICAN MANAGEMENT KANE BIOTECH: RESUMPTION OF COMMERCIAL ACTIVITIES IN US & CANADA FOR ITS REVYVE ANTIMICROBIAL WOUND GEL PRODUCT LINE Source text: ID:nGNX5d8sZT Further company coverage: KNE.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update